Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Uncertainty: Confidence Intervals00:54

Uncertainty: Confidence Intervals

9.9K
The confidence interval is the range of values around the mean that contains the true mean. It is expressed as a probability percentage. The interpretation of a 95% confidence interval, for instance, is that the statistician is 95% confident that the true mean falls within the interval. The upper and lower limits of this range are known as confidence limits. The confidence limits for the true mean are estimated from the sample's mean, the standard deviation, and the statistical factor...
9.9K
Propagation of Uncertainty from Random Error00:59

Propagation of Uncertainty from Random Error

1.9K
An experiment often consists of more than a single step. In this case, measurements at each step give rise to uncertainty. Because the measurements occur in successive steps, the uncertainty in one step necessarily contributes to that in the subsequent step. As we perform statistical analysis on these types of experiments, we must learn to account for the propagation of uncertainty from one step to the next. The propagation of uncertainty depends on the type of arithmetic operation performed on...
1.9K
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

357
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
357
Systematic Error: Methodological and Sampling Errors01:15

Systematic Error: Methodological and Sampling Errors

8.7K
In the case of systematic errors, the sources can be identified, and the errors can be subsequently minimized by addressing these sources. According to the source, systematic errors can be divided into sampling, instrumental, methodological, and personal errors.
Sampling errors originate from improper sampling methods or the wrong sample population. These errors can be minimized by refining the sampling strategy. Defective instruments or faulty calibrations are the sources of instrumental...
8.7K
Propagation of Uncertainty from Systematic Error01:10

Propagation of Uncertainty from Systematic Error

1.4K
The atomic mass of an element varies due to the relative ratio of its isotopes. A sample's relative proportion of oxygen isotopes influences its average atomic mass. For instance, if we were to measure the atomic mass of oxygen from a sample, the mass would be a weighted average of the isotopic masses of oxygen in that sample. Since a single sample is not likely to perfectly reflect the true atomic mass of oxygen for all the molecules of oxygen on Earth, the mass we obtain from this...
1.4K
Uncertainty: Overview00:59

Uncertainty: Overview

1.6K
In analytical chemistry, we often perform repetitive measurements to detect and minimize inaccuracies caused by both determinate and indeterminate errors. Despite the cares we take, the presence of random errors means that repeated measurements almost never have exactly the same magnitude. The collective difference between these measurements - observed values - and the estimated or expected value is called uncertainty. Uncertainty is conventionally written after the estimated or expected value.
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physician explanation of Z-coded homelessness in medicaid claims.

Health services & outcomes research methodology·2026
Same author

Emergence and Potential of State Healthcare Cost Growth Benchmark Programs.

Journal of health politics, policy and law·2026
Same author

Structured adult learning outside school or job associates with improved plasma markers of age.

medRxiv : the preprint server for health sciences·2026
Same author

Implementing and retaining a large-scale technology-mediated cohort to study HIV incidence and PrEP uptake among vulnerable cisgender men as well as transgender individuals in the United States, the Together 5000 cohort.

American journal of epidemiology·2025
Same author

Factors associated with HIV status non-disclosure among people entering care at IeDEA sites in Cameroon: a cross-sectional study.

AIDS research and therapy·2025
Same author

Classification of Homelessness in Medicaid Claims and Homeless Services Administrative Records: Application of a Concordance Analysis Framework.

AJPM focus·2025

Related Experiment Video

Updated: Apr 30, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K

Statistical uncertainty in the Medicare shared savings program.

Derek DeLia1, Donald Hoover2, Joel C Cantor1

  • 1Rutgers University-Center for State Health Policy.

Medicare & Medicaid Research Review
|May 7, 2014
PubMed
Summary

Statistical risks in the Medicare Shared Savings Program (MSSP) are higher than expected, especially for smaller Accountable Care Organizations (ACOs). Analysis reveals significant probabilities of incorrect payments and penalties, impacting financial planning.

Keywords:
CapitationDRGsHealth Care CostsHealth Care FinancingHealth Care Organizations and SystemsHealth EconomicsHealth PolicyIncentives in Health CareInsuranceLawMedicare, EconometricsPayment Systems: FFSPoliticsPremiumsRBRVSRegulationRisk Adjusted Payments etc.

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.3K

Related Experiment Videos

Last Updated: Apr 30, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.3K

Area of Science:

  • Health Economics
  • Healthcare Policy
  • Statistical Modeling

Background:

  • The Medicare Shared Savings Program (MSSP) incentivizes Accountable Care Organizations (ACOs) to reduce healthcare costs.
  • Understanding the statistical risks associated with MSSP payment formulas is crucial for financial planning and program efficiency.

Purpose of the Study:

  • To analyze the statistical risks and probabilities of inappropriate payments, denials, and financial penalties for ACOs under the MSSP.
  • To assess how ACO enrollment size and generated savings influence these risks.

Main Methods:

  • Calculated probabilities of incorrect payment outcomes (reward, denial, penalty) based on simulated real savings (0-10%).
  • Modeled expected payments from CMS to ACOs under various savings scenarios.
  • Examined the impact of ACO enrollment size (e.g., 5,000 vs. 50,000 enrollees) on risk probabilities.

Main Results:

  • Incorrect payment outcomes are highly dependent on ACO enrollment size; smaller ACOs face substantially higher risks.
  • For a 5,000-enrollee ACO, probabilities of inappropriate reward or penalty can reach 0.24-0.26, while for a 50,000-enrollee ACO, these probabilities drop to 0.02.
  • Probability of payment denial decreases with increasing real savings but remains significant (≥0.15) for small ACOs even with 5-7% savings.

Conclusions:

  • The MSSP exhibits greater statistical uncertainty than previously understood, necessitating careful financial and administrative planning by CMS and ACOs.
  • Refined analytic strategies are needed to optimize ACO payment formulas for long-term program efficiency.
  • Findings underscore the importance of considering statistical uncertainty in designing and managing value-based care initiatives.